A comparison of the usability of two types of disposable pen (FlexPen versus Humalog kit) containing rapid-acting insulin analogs

被引：0
|
作者：
Asakura, T
Seino, H
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A102 / A102
页数：1
相关论文
共 16 条
  • [1] Compare usability of two types of disposable pen (FlexPen versus Humalog Pen) containing rapidacting insulin analogues
    Asakura, T
    Seino, H
    Nicklasson, L
    VALUE IN HEALTH, 2004, 7 (03) : 344 - 344
  • [2] Comparison of usability and patient preference for the new disposable insulin device SoloStar versus FlexPen, Lilly disposable pen, and a prototype pen: An open-label study
    Haak, Thomas
    Edelman, Steven
    Walter, Claudia
    Lecointre, Brigitte
    Spollett, Gerry
    CLINICAL THERAPEUTICS, 2007, 29 (04) : 650 - 660
  • [3] Safety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin
    Kitabchi, Abbas E.
    Gosmanov, Aidar R.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (02): : 136 - 141
  • [4] Comparison of the efficacy and safety of rapid-acting insulin analogs, lispro versus aspart, in the treatment of diabetes: a systematic review of randomized controlled trials
    Kapur, Rahul
    Mittra, Shivani
    Tonpe, Geetanjali
    P, P.
    Raj, Praveen
    Gudat, Uwe
    Athalye, Sandeep N.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (06) : 543 - 561
  • [5] CYTOTOXIC EFFECT OF THREE COMMERCIAL RAPID-ACTING INSULIN ANALOGS AND THEIR PHENOLIC EXCIPIENTS ON FOUR HUMAN IMMUNE CELL TYPES
    Woodley, W. D.
    Gerth, S. S.
    Morel, D. R.
    Borchert, K.
    Godfrey, L.
    Alarcoen, J.
    Chandler, L.
    Herrmann, N.
    Pettis, R. J.
    Bolick, N. G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A115 - A116
  • [6] Comparative Effectiveness of Various Long-Acting (Lantus, Levemir), Rapid-Acting (Apidra, Humalog, Novalog) Insulin Analogs and Their Combinations for Type 1 Diabetes (T1D) Patients
    Woodwyk, Alyssa
    Beam, Craig
    DIABETES, 2016, 65 : A253 - A253
  • [7] Comparison of metabolic and mitogenic response in vitro of the rapid-acting insulin lispro product SAR342434, and US- and EU-approved Humalog®
    Korn, Marcus
    Wohlfart, Paulus
    Gossas, Thomas
    Kullman-Magnusson, Mari
    Niederhaus, Birgit
    Dedio, Juergen
    Tennagels, Norbert
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, 109
  • [8] Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes
    Al Shamsi, Aisha Mohammed
    PEDIATRICS, 2008, 122 (03) : 675 - 676
  • [9] Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes - Reply
    Hassan, Krishna V.
    PEDIATRICS, 2008, 122 (03) : 676 - 676
  • [10] A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery
    Hirsch, Irl B.
    Beck, Roy W.
    Marak, Martin Chase
    Calhoun, Peter
    Manessis, Adham
    Salhin, Amna
    Manessis, Anastasios
    Coviello, Andrea D.
    Bhargava, Anuj
    Thorsell, Ashley
    Castillo, Astrid Atakov
    Bode, Bruce W.
    Levister, Camilla
    Levy, Carol J.
    Donahue, Cassandra
    Cordero, Christian
    Beatson, Christie
    Langel, Christine R.
    Jacobson, Christopher
    Kurek, Corey
    Cruse, Dana
    Pickering, David
    Tamarez, Denisa
    Steenkamp, Devin W.
    Desjardins, Donna
    Aleppo, Grazia
    O'Malley, Grenye
    Akturk, Halis K.
    Diner, Jamie
    Baran, Jesica D.
    Buse, John B.
    Ruedy, Katrina
    Codorniz, Kevin
    Klein, Klara R.
    Castorino, Kristin
    Jordan, Lin Fan
    Kipnes, Mark
    Church, Mei Mei
    Hamdy, Osama
    Raskin, Philip
    Nguyen, Quang T.
    Weinstock, Ruth S.
    Lee, Scott
    Rizvi, Shafaq
    Bzdick, Suzan
    Rodriguez, Tahereh Ghorbani
    Salah, Tareq
    Blevins, Thomas
    Kudva, Yogish C.
    Haider, Zehra
    DIABETES CARE, 2024, 47 (09)
12